| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joshua S. Lev | CFO and Interim President | 2026-05-28 | 6,667 | $9.00 | $60.00kSell |
| Joshua S. Lev | CFO and Interim President | 2026-05-22 | 3,000 | $6.50 | $19.50kSell |
| Thomas J. Errico | Director | 2026-05-21 | 9,992 | $5.99 | $59.85kBuy |
| Thomas J. Errico | Director | 2026-05-20 | 8 | $5.98 | $47.84Buy |
| Daniel S. Goldberger | Insider | 2026-04-23 | 80,000 | $6.80 | $544.00kSell |
| Daniel S. Goldberger | Insider | 2026-04-10 | 16,072 | $6.02 | $96.75kSell |
| Thomas J. Errico | Director | 2026-03-19 | 19,252 | $6.43 | $123.79kBuy |
| Thomas J. Errico | Director | 2026-03-19 | 22,803 | $4.35 | $99.19kBuy |
| Daniel S. Goldberger | Chief Executive Officer | 2026-01-26 | 20,375 | $7.47 | $152.20kBuy |
| Joshua S. Lev | Chief Financial Officer | 2025-12-04 | 2,500 | $5.05 | $12.63kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph P. Errico | 46.55% | 3,861,942 | $22.71M | Insider |
| Merck Global Health Innovation Fund LLC | 40.33% | 3,346,032 | $19.67M | Insider |
| James L. L. Tullis | 24.28% | 2,014,110 | $11.84M | Insider |
| Thomas J. Errico | 12.84% | 1,065,161 | $6.26M | Insider |
| Core Ventures II LLC | 7.79% | 646,342 | $3.80M | Insider |
| Peter S. Staats | 5.74% | 476,419 | $2.80M | Insider |
| Charles Steve Theofilos | 5.58% | 462,758 | $2.72M | Insider |
| Francis R. Amato | 4.44% | 368,355 | $2.17M | Insider |
| Daniel S. Goldberger | 2.55% | 211,471 | $1.24M | Insider |
| Vanguard Capital Management LLC | 2.44% | 202,644 | $1.19M | Institution |